Annual Drug Patent Expirations for FOLOTYN Folotyn is a drug marketed by Acrotech and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Acrotech drug FOLOTYN appeared first…
FOLOTYN (pralatrexate) Acrotech Patent: 6,028,071 Expiration: Jul 16, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug P…
Drug Patent Expirations for the Week of July 10, 2022 Read Post »
Annual Drug Patent Expirations for ULESFIA Ulesfia is a drug marketed by Shionogi Inc and is included in one NDA. There are two patents protecting this drug and one Paragraph…
The post New patent expiration for Shionogi Inc drug ULESFIA appeared first …
New patent expiration for Shionogi Inc drug ULESFIA Read Post »
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-three patents protecting…
The post New patent expiration for NOVO drug SAXENDA appeared first…
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-three patents protecting…
The post New patent expiration for NOVO drug SAXENDA appeared first…
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-three patents protecting…
The post New patent expiration for NOVO drug SAXENDA appeared first…
Annual Drug Patent Expirations for LUSEDRA Lusedra is a drug marketed by Eisai Inc and is included in one NDA. There is one patent protecting this drug. This drug has…
The post New patent expiration for Eisai Inc drug LUSEDRA appeared first on DrugPate…
New patent expiration for Eisai Inc drug LUSEDRA Read Post »
Annual Drug Patent Expirations for LUSEDRA Lusedra is a drug marketed by Eisai Inc and is included in one NDA. There is one patent protecting this drug. This drug has…
The post New patent expiration for Eisai Inc drug LUSEDRA appeared first on DrugPate…
New patent expiration for Eisai Inc drug LUSEDRA Read Post »
Annual Drug Patent Expirations for STIVARGA Stivarga is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent expiration for Bayer Hlthcare drug STIVARGA appeared fi…
New patent expiration for Bayer Hlthcare drug STIVARGA Read Post »
Annual Drug Patent Expirations for LUPRON+DEPOT Lupron Depot is a drug marketed by Abbvie Endocrine Inc and is included in five NDAs. It is available from one supplier. There are…
The post New patent expiration for Abbvie Endocrine drug LUPRON DEPOT ap…
New patent expiration for Abbvie Endocrine drug LUPRON DEPOT Read Post »